Journals Menu
Guidelines & Policies
Follow SCIRP
Contact us
[email protected]
WhatsApp +86 18163351462
(WhatsApp)
Click here to send a message to me 1655362766

SCIRP WeChat

International Journal of Clinical Medicine

International Journal of Clinical Medicine

International Journal of Clinical Medicine

ISSN Print: 2158-284X
ISSN Online: 2158-2882
www.scirp.net/journal/ijcm
E-mail: [email protected]
"Topical CuradermBEC5 Therapy for Periocular Nonmela-noma Skin Cancers: A Review of Clinical Outcomes"
written by Bill E. Cham,
published by International Journal of Clinical Medicine, Vol.4 No.5, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Utility potential of the aggressive invasive Solanum elaeagnifolium Cav. (Solanaceae) as an option to control its expansion: bioactive compounds and medicinal …
Euro-Mediterranean …, 2024
[2] The Value of Excipients and the Required Understanding of the Biological System in Product Development: An Impactful Example of Curaderm, a Topical Skin Cancer …
International Journal of …, 2024
[3] The Pharmacology of Curaderm in the Treatment of Basal Cell Carcinoma
Clin Med Rev Case Rep, 2022
[4] Combination Treatment with BEC and Cisplatin Synergistically Augments Anticancer Activity and Results in Increased Absolute Survival
2020
[5] Curaderm, the Long-Awaited Breakthrough for Basal Cell Carcinoma
2020
[6] First in Man Topical Treatment of Melanoma with Solasodine Glycosides in a Formulation Curaderm: A Case Report
2020
[7] Outside the Box Cancer Therapies: Alternative Therapies That Treat and Prevent Cancer
2019
[8] “Dr. Stengler and Dr. Anderson expertly provide clear, practical tools that can possibly save your life or someone close to you. By harnessing the healing power …
2018
[9] Solasodine, Solamargine and Mixtures of Solasodine Rhamnosides: Pathway to Expansive Clinical Anticancer Therapies
2017
[10] A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity. Relevance to BEC and Solamargine, Example of a …
2015
[11] A Standardized Plant Extract Containing a Target Compound Is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical …
2015
[12] Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases
Medicinal research reviews, 2015
[13] A Standardized Plant Extract Containing a Target Compound is Acceptable as a Potent Therapeutic Entity: Relevance to BEC and Solamargine, a Topical Clinical Formulation Curaderm BEC5
Journal of Cancer Treatment and Research, 2015
[14] Treatment of Skin Cancer with a Selective Apoptotic-Inducing CuradermBEC5 Topical Cream Containing Solasodine Rhamnosides
International Journal of Clinical Medicine, 2015
[15] Treatment of Non Melanoma Skin Cancers: An Intra-Comparison Study of CuradermBEC5 and Various Established Modalities
Journal of Cancer Therapy, 2015
[16] Topical Cream Curadermbec5 Treats a Recalcitrant Basal Cell Carcinoma
2015
[17] AGROBACTERIUM RHIZOGENES-MEDIATED HAIRY ROOT OF APPLE OF SODOM (SOLANUM MAMMOSUM L.) FOR OPTIMIZED PRODUCTION OF …
2015
[18] A standardized plant extract containing a target compound is acceptable as a potent therapeutic entity: Relevance to BEC and solamargine, a topical clinical …
2015
[19] A review of solasodine rhamnosides therapy for in-situ squamous cell carcinoma on the penis
British Journal of Medicine and Medical Research, 2014
[20] A review of solasodine rhamnosides therapy for in-situ squamous cell carcinoma on the penis.
British Journal of Medicine and Medical Research, 2014
Special Issues
Follow SCIRP
Contact us
[email protected]
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top